These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34915143)

  • 1. Mechanism on antigen delivery under mucosal vaccination using cell-penetrating peptides immobilized at multiple points on polymeric platforms.
    Ukawa M; Endo R; Yagi H; Tomono T; Miyata K; Shigeno K; Tobita E; Uto T; Baba M; Sakuma S
    Int J Pharm; 2022 Feb; 613():121376. PubMed ID: 34915143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Safe Adjuvant for Mucosal Vaccination.
    Ukawa M; Tanishita S; Yagi H; Yoshida Y; Tomono T; Shigeno K; Tobita E; Uto T; Baba M; Sakuma S
    Mol Pharm; 2019 Mar; 16(3):1105-1118. PubMed ID: 30715891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-penetrating peptide-linked polymers as carriers for mucosal vaccine delivery.
    Sakuma S; Suita M; Inoue S; Marui Y; Nishida K; Masaoka Y; Kataoka M; Yamashita S; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Uto T; Baba M
    Mol Pharm; 2012 Oct; 9(10):2933-41. PubMed ID: 22953762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of d-Octaarginine-Linked Polymers as Promising Adjuvants for Mucosal Vaccination through Influenza Virus Challenge.
    Miyata K; Mohri K; Egawa T; Endo R; Morimoto N; Ochiai K; Hiwatari K; Tsubaki K; Tobita E; Uto T; Baba M; Sakuma S
    Bioconjug Chem; 2016 Aug; 27(8):1865-71. PubMed ID: 27463562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactivity of immunoglobulin A secreted on the nasal mucosa in mice nasally inoculated with inactivated H1N1 influenza A viruses in the presence of D-octaarginine-linked polymers.
    Sakuma S; Morimoto N; Nishida K; Murakami T; Egawa T; Endo R; Kataoka M; Yamashita S; Miyata K; Mohri K; Ochiai K; Hiwatari K; Koike S; Tobita E; Uto T; Baba M
    Eur J Pharm Biopharm; 2015 May; 92():56-64. PubMed ID: 25720816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the Chemical Structures of Oligoarginines Conjugated to Biocompatible Polymers as a Mucosal Adjuvant on Antibody Induction in Nasal Cavities.
    Mohri K; Miyata K; Egawa T; Tanishita S; Endo R; Yagi H; Ukawa M; Ochiai K; Hiwatari KI; Tsubaki K; Shigeno K; Tobita E; Uto T; Baba M; Sakuma S
    Chem Pharm Bull (Tokyo); 2018; 66(4):375-381. PubMed ID: 29607903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Penetrating Peptide Penetratin as a Potential Tool for Developing Effective Nasal Vaccination Systems.
    Muto K; Kamei N; Yoshida M; Takayama K; Takeda-Morishita M
    J Pharm Sci; 2016 Jun; 105(6):2014-2017. PubMed ID: 27155764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Cell-Penetrating Peptides Anchored to Polysaccharide Platforms Applied via Various Mucosal Routes as an Absorption Enhancer.
    Yagi H; Tomono T; Handa Y; Saito N; Ukawa M; Miyata K; Shigeno K; Sakuma S
    Mol Pharm; 2023 Jan; 20(1):303-313. PubMed ID: 36484773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of cell-penetrating peptide-linked polymers physically mixed with poorly membrane-permeable molecules on cell membranes.
    Sakuma S; Suita M; Yamamoto T; Masaoka Y; Kataoka M; Yamashita S; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Hashizume A; Tachikawa H; Kimura R; Ishimaru Y; Kasai A; Maeda S
    Eur J Pharm Biopharm; 2012 May; 81(1):64-73. PubMed ID: 22306700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligoarginine-linked polymers as a new class of penetration enhancers.
    Sakuma S; Suita M; Masaoka Y; Kataoka M; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Yamashita S
    J Control Release; 2010 Dec; 148(2):187-96. PubMed ID: 20800631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Protective Abilities of Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Mucosal Adjuvant against Infection with Heterologous Influenza Viruses.
    Tanishita S; Ukawa M; Tomono T; Yoshida Y; Tsujioka T; Miyata K; Tobita E; Uto T; Baba M; Sakuma S
    Bioconjug Chem; 2019 Dec; 30(12):3028-3037. PubMed ID: 31738536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatible Polymers Modified with d-Octaarginine as an Absorption Enhancer for Nasal Peptide Delivery.
    Miyata K; Ukawa M; Mohri K; Fujii K; Yamada M; Tanishita S; Higashitarumi S; Ishizaki S; Kumagai H; Ochiai K; Hiwatari KI; Tsubaki K; Shigeno K; Tobita E; Kobayashi H; Sakuma S
    Bioconjug Chem; 2018 May; 29(5):1748-1755. PubMed ID: 29648441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal absorption enhancement of protein drugs independent to their chemical properties in the presence of hyaluronic acid modified with tetraglycine-L-octaarginine.
    Tomono T; Yagi H; Ukawa M; Ishizaki S; Miwa T; Nonomura M; Igi R; Kumagai H; Miyata K; Tobita E; Kobayashi H; Sakuma S
    Eur J Pharm Biopharm; 2020 Sep; 154():186-194. PubMed ID: 32681963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of Translationally Controlled Tumor Protein-Derived Protein Transduction Domains as Antigen Carriers for Nasal Vaccine Delivery.
    Bae HD; Lee J; Jin XH; Lee K
    Mol Pharm; 2016 Sep; 13(9):3196-205. PubMed ID: 27454469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of D-Octaarginine-Linked Polymers as an in Vitro Transfection Tool for Biomolecules.
    Mohri K; Morimoto N; Maruyama M; Nakamoto N; Hayashi E; Nagata K; Miyata K; Ochiai K; Hiwatari K; Tsubaki K; Tobita E; Ishimaru Y; Maeda S; Sakuma S
    Bioconjug Chem; 2015 Aug; 26(8):1782-90. PubMed ID: 26252905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-conjugated N-trimethylaminoethylmethacrylate chitosan nanoparticles induce strong immune responses after nasal administration.
    Liu Q; Zheng X; Zhang C; Shao X; Zhang X; Zhang Q; Jiang X
    Pharm Res; 2015 Jan; 32(1):22-36. PubMed ID: 24970313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Penetrating Peptide-Based Redox-Sensitive Vaccine Delivery System for Subcutaneous Vaccination.
    Wang K; Yang Y; Xue W; Liu Z
    Mol Pharm; 2018 Mar; 15(3):975-984. PubMed ID: 29359945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration.
    Xu H; Alzhrani RF; Warnken ZN; Thakkar SG; Zeng M; Smyth HDC; Williams RO; Cui Z
    Mol Pharm; 2020 Sep; 17(9):3259-3269. PubMed ID: 32787271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal absorption of antibody drugs enhanced by cell-penetrating peptides anchored to a platform of polysaccharides.
    Tomono T; Yagi H; Igi R; Tabaru A; Fujimoto K; Enomoto K; Ukawa M; Miyata K; Shigeno K; Sakuma S
    Int J Pharm; 2023 Nov; 647():123499. PubMed ID: 37832700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal vaccination using claudin-4-targeting.
    Kakutani H; Kondoh M; Fukasaka M; Suzuki H; Hamakubo T; Yagi K
    Biomaterials; 2010 Jul; 31(20):5463-71. PubMed ID: 20398936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.